Quantcast
Last updated on April 17, 2014 at 16:36 EDT

Latest European Hematology Association Stories

2013-05-29 00:23:45

- Latest Phase III research on Afinitor® in advanced HER2 positive breast cancer EAST HANOVER, N.J., May 29, 2013 /PRNewswire/ -- Novartis will present new findings in the treatment of advanced cancers and other diseases with 170 abstracts at two prominent medical meetings. Research across the extensive Novartis product portfolio and pipeline showcases the progress in advancing care for patients with cancer and hematological diseases. Clinical data from multiple...

2012-06-17 22:22:31

AMSTERDAM, June 18, 2012 /PRNewswire/ -- The European Hematology Association (EHA), the American Society of Hematology (ASH), and the European Cancer Patient Coalition (ECPC) joined in issuing a common call to action in an effort to mitigate shortages of hematologic drugs in Europe, the United States and around the world. The collective made the announcement today following the EHA-ASH Joint Symposium at the 17th EHA Congress in Amsterdam which was dedicated to the...

2012-06-16 02:20:16

AMSTERDAM, June 16, 2012 /PRNewswire/ -- Pharmacyclics, Inc (Nasdaq: PCYC) announced today at the 17th Congress of European Hematology Association updated results from two clinical trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). The ibrutinib clinical updates at EHA released in two oral presentations include: 1) updated safety and efficacy data from the Phase...

2012-06-16 02:20:14

AMSTERDAM, June 16, 2012 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) joined the European Hematology Association (EHA) and the European Cancer Patient Coalition (ECPC) today in issuing a common call to action in an effort to mitigate shortages of hematologic drugs in the United States and around the world. The collective made the announcement today following the EHA-ASH Joint Symposium at the 17th EHA Congress in Amsterdam, a portion of which was dedicated to addressing...

2012-06-15 10:23:01

PARIS, June 15, 2012 /PRNewswire/ -- Results Presented at 17th Congress of the European Hematology Association Bristol-Myers Squibb Company (NYSE:BMY) and Otsuka Pharmaceutical Europe Ltd., today announced six-year follow-up results from a Phase 3 randomised, open-label, dose-optimisation study of SPRYCEL(R) (dasatinib) in Philadelphia chromosome-positive (Ph+) chronic-phase chronic myeloid leukaemia (CP-CML) adult patients resistant or intolerant to Glivec(R)...

2012-06-14 22:20:39

AMSTERDAM, June 15, 2012 /PRNewswire/ -- At the 17th Congress of EHA in Amsterdam the EHA Jean Bernard Lifetime Achievement Award will be handed to Professor Laurent Degos and the EHA Jose Carreras Award to Professor Jesus San Miguel. Laurent Degos will be the fifth recipient of the Jean Bernard Lifetime Achievement Award which was presented for the first time at the 13th Congress in Copenhagen. This award was established to honor outstanding physicians and scientists for...

2012-05-22 02:26:24

SUNNYVALE, Calif., May 22, 2012 /PRNewswire/ -- Pharmacyclics, Inc. (NASDAQ: PCYC) today announced that clinical abstracts on Bruton's Tyrosine Kinase inhibitor, ibrutinib (formerly, PCI-32765) have been selected for oral presentations at the 17th Congress of the European Hematology Association (EHA), June 14-17, 2012 in Amsterdam, The Netherlands. The update on data presented specifically includes: 1) updated safety and efficacy data, including progression free survival, from the...

2012-05-21 02:24:45

AMSTERDAM, May 21, 2012 /PRNewswire/ -- 3rd Invitation to 17th Congress of EHA - European Hematology Association The Board of the European Hematology Association (EHA) has the pleasure to cordially invite you, as a member of the press, to the 17th Congress of EHA. More than 9,000 participants from around the world are expected at the upcoming Congress at the RAI Congress Center in Amsterdam from June 14-17, 2012. About the EHA Annual Congress: The...

2012-05-04 02:25:12

AMSTERDAM, May 4, 2012 /PRNewswire/ -- - 2nd Invitation to 17th Congress of EHA - European Hematology Association The Board of the European Hematology Association (EHA) has the pleasure to cordially invite you, as a member of the press, to the 17th Congress of EHA. More than 9,000 participants from around the world are expected at the upcoming Congress at the RAI Congress Center in Amsterdam from June 14-17, 2012. About the EHA Annual Congress: The...

2012-04-10 02:26:21

AMSTERDAM, April 10, 2012 /PRNewswire/ -- Invitation 17th Congress of EHA - European Hematology Association The Board of the European Hematology Association (EHA) has the pleasure to cordially invite you, as a member of the press, to the 17th Congress of EHA. More than 9,000 participants from around the world are expected at the upcoming 17th Congress of the European Hematology Association at the RAI Congress Center in Amsterdam from June 14-17, 2012. About...